Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Double Blind, Multicentre, Randomized, Placebo-controlled Trial to Evaluate Safety and Efficacy of Pitolisant in Children From 6 to Less Than 18 Years With Narcolepsy With/Without Cataplexy, Followed by a Prolonged Open-label Period

NCT02611687 is registered in ClinicalTrials.gov with Bioprojet as lead sponsor.

NCT NCT02611687
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02611687 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Double Blind, Multicentre, Randomized, Placebo-controlled Trial to Evaluate Safety and Efficacy of Pitolisant in Children From 6 to Less Than 18 Years With Narcolepsy With/Without Cataplexy, Followed by a Prolonged Open-label Period
Lead sponsor
Bioprojet
Phase
Phase 3
Overall status
Completed
Start date
June 6, 2016
Completion date
June 5, 2025
Enrollment
110 (actual)
Sites
11

Conditions

As the registry lists them; a condition with its own page is linked.

narcolepsy with cataplexy, narcolepsy without cataplexy